The Position

The Director, Scientific Publications & Information serves as the US strategic owner for integrated scientific publications, scientific information/knowledge services, and evidence dissemination excellence across therapeutic areas and lifecycle. The role leads a team of publication and information professionals; sets multi-year strategy; aligns US and global Medical Affairs, evidence generation, and launch/lifecycle priorities; and ensures compliant, timely, high-quality dissemination of company-sponsored and externally authored scientific data. Beyond content creation, the Director builds strategic information capabilities, advances responsible AI/digital solutions, manages vendors and budgets, and provides executive-ready insights that support Medical Affairs decision-making.

Relationships

Reports to the Head of Scientific Communications and directly leads the Scientific Publications & Information (SP&I) team, including potential Global Business Services/shared-service resources. Partners with USO, IO and Global Medical Affairs, Clinical Development, Clinical Data Science/Evidence, Biostatistics, HEOR/RWE, Regulatory, Legal/Compliance, AI and Machine Learning, IT, Scientific Information, Clinical Reporting/Medical Writing, and affiliate/HQ publication partners.

Leads, stands for (and delegates) SP&I on Core/Extended Medical Teams, Launch/Asset Planning teams, Publication Planning Groups (or IEP), Core Publications Working Groups, Global Project Teams(as needed/delegated by AVP), evidence planning forums, and governance bodies. Externally, manages compliant relationships with authors, investigators, external experts/KOLs, journal editors/publishers, congress organizers, medical writing agencies, publication/information vendors, and professional organizations/industry consortia.

Essential Functions

• General / Strategic Leadership and Governance
  • Operates independently as the US functional leader for SP&I strategy, governance, operational excellence, and capability building across therapeutic areas
  • Owns and refreshes integrated US publication, scientific information, and evidence dissemination strategy by therapy area/asset; ensures alignment with global plans, US medical strategy, launch/lifecycle priorities, data milestones, and stakeholder needs
  • Chairs or oversees publication planning groups, governance forums, and annual planning workshops; drives prioritization, risk management, decision documentation, and escalation of strategic or compliance issues
  • Translates medical strategy, evidence gaps, landscape/competitive intelligence, stakeholder insights, and data milestones into prioritized publication and information plans
  • Defines and reports KPIs/dashboards for plan progress, submission/publication timelines, scientific quality, journal/congress strategy, reach/engagement, author experience, compliance, budget/vendor performance, and operational efficiency
  • Develops, updates, and trains stakeholders on SOPs/work practices for GPP 2022, ICMJE authorship/contributorship, disclosures, data transparency, copyright, publication systems, AI use, and audit readiness
  • Provides executive-ready insights and recommendations to Medical Affairs leadership, Core/Extended Medical Teams, launch teams, and global partners
  • Manages SP&I base/launch budgets, forecasting, phasing, vendor sourcing, performance management, resource allocation, and continuous improvement
• Publications / Scientific Communications
  • Accountable for strategy, quality, scientific rigor, and governance of manuscripts, abstracts, posters, oral presentations, plain-language summaries, publication extenders, scientific platforms, and related evidence dissemination assets
  • Develops integrated journal, congress, and digital dissemination strategies aligned to launch/lifecycle milestones, data availability, scientific narrative, and external stakeholder needs
  • Ensures clinical, RWE/HEOR, biomarker, patient-reported outcome, preclinical, health literacy/plain-language, and disease-state publications are planned and governed according to data availability and business priorities
  • Leads global-local alignment and ensures US publication needs, evidence gaps, and stakeholder insights are represented in global publication plans
  • Leads author/external expert engagement strategy and ensures compliant authorship criteria, contributorship, disclosures, acknowledgments, author agreements, and publication independence
  • Oversees publication planning and author engagement systems, including Datavision, Envision, HCP Rex, and related dashboards, to maintain transparency, workflow discipline, metrics, and inspection readiness
  • Provides guidance and training to internal/external stakeholders on publication strategy, scientific narrative, publication planning processes, and ethical publication practices
• Scientific Information / Knowledge Strategy
  • Leads scientific information as a strategic knowledge management and decision-support capability, not only a document delivery/request fulfillment service
  • Oversees literature surveillance, landscape assessments, competitive intelligence, gap analyses, search reports, alerts, document delivery, subscription strategy, and copyright compliance for internal stakeholders
  • Creates decision-ready insights from published literature, congress data, pipeline/competitor activity, and internal evidence plans to support Medical Affairs, launch teams, evidence generation, field medical, and leadership decision-making
  • Establishes governance for scientific information libraries, taxonomies, metadata, search optimization, record retention, copyright/licensing, and information-access controls
  • Evaluates document delivery streams, subscriptions, vendors, and literature/alerting processes to reduce redundancy, improve quality, and manage cost
• AI, Digital, and Operational Innovation
  • Owns the responsible AI/automation and digital roadmap for SP&I; priority use cases may include literature surveillance, gap analysis, data extraction/synthesis support, plain-language summary support, workflow automation, metrics dashboards, and knowledge management
  • Partners with AI/Machine Learning, IT, Legal, Compliance, Privacy, and business stakeholders to ensure human oversight, data security, copyright compliance, validation, quality control, and change management
  • Identifies process improvements and technology/vendor solutions that increase speed, quality, transparency, and scalability while maintaining compliance

Physical Requirements

10-20% overnight travel required.

Development of People

Ensure that reporting personnel have individual development plans (IDP), with annual goals and measurements that are consistent with the priorities of the business, and that interim reviews are held so that their work is focused on those priorities, and they understand their level of accountability for results and the measurement process. Ensure that the IDP forms include completed learning and aspiration plans and are in place for all reporting personnel to enable the achievement of goals and capability to assume increased levels of responsibility. Manage the application and communication of all Novo Nordisk policies, procedures, and Novo Nordisk Way.

Qualifications

• Advanced degree in life sciences, medicine, pharmacy, public health/epidemiology, health services research, or a related biomedical discipline required; PharmD, PhD, MD/DO strongly preferred. MS/MPH acceptable with relevant experience
• ISMAP required. CMPP certification through ISMPP required at hire or must be obtained within 12 months of hire; active ISMPP participation expected
• Minimum 10+ years of relevant experience for all candidates across academia, pharma/biotech, medical communications agency, publishing, Medical Affairs, Clinical Development, HEOR/RWE, or adjacent scientific/medical communication functions
• Experience must include 7+ years in scientific publications, scientific communications, publication planning, medical communications, medical information, or adjacent biopharma evidence dissemination roles, and a minimum of 3+ years of people leadership/line-management experience
• Sponsor-side pharma/biotech experience strongly preferred; agency-only candidates should demonstrate strategic client leadership, publication planning ownership, budget/vendor governance, and matrix influence beyond writing/content execution
• Demonstrated excellence in publication strategy, scientific narrative/platform development, evidence dissemination planning, publication governance, author engagement, and impact measurement; able to critically review and improve scientific content
• Advanced understanding of drug development, launch/lifecycle planning, clinical trial design/reporting, statistics, RWE/HEOR, medical/scientific exchange, data disclosure, FDA/OPDP guardrails, OIG/PhRMA expectations, GPP 2022, ICMJE, AMA, copyright, and company SOPs
• Proven leadership in complex global-local matrix environments, including strategy translation, portfolio prioritization, cross-functional influence, issue escalation, change management, and executive communication
• Portfolio/program management expertise with ability to manage multiple assets, vendors, authors, timelines, budgets, governance requirements, and launch-sensitive deliverables
• Proficiency with publication management systems, author engagement systems, literature databases/search platforms, copyright/subscription portals, dashboards/analytics tools, and responsible AI/digital solutions for publications and scientific information
• Superior written and verbal communication, executive presentation, influence, negotiation, and stakeholder management skills; strong attention to quality, ethics, and operational discipline

The base compensation range for this position is $215,000 to $275,000. Base compensation is determined based on a number of factors. This position is also eligible for a company bonus based on individual and company performance. Novo Nordisk offers long-term incentive compensation and or company vehicles depending on the position's level or other company factors.

Employees are also eligible to participate in Company employee benefit programs including medical, dental and vision coverage; life insurance; disability insurance; 401(k) savings plan; flexible spending accounts; employee assistance program; tuition reimbursement program; and voluntary benefits such as group legal, critical illness, identity theft protection, pet insurance and auto/home insurance. The Company also offers time off pursuant to its sick time policy, flex-able vacation policy, and parental leave policy.